Skip to content

Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer

Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02495155
Acronym
PROSPECT
Enrollment
45
Registered
2015-07-13
Start date
2015-06-30
Completion date
2016-06-30
Last updated
2016-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Fatigue, Insomnia, Pain

Brief summary

In order to determine the acceptability of a breast cancer-specific cognitive behavioral therapy intervention, as well as to obtain preliminary data to assess efficacy in managing symptoms, the investigators will ask 45 breast cancer survivors with moderate insomnia, fatigue, and/or pain to use the investigators' internet-based intervention for 8 weeks and to complete patient-reported outcomes assessments before and after the 8 week intervention.

Interventions

BEHAVIORALPROSPECT

PROSPECT is an internet-based exercise and behavioral symptom management program developed for patients who experience long-term side effects from cancer treatment. The cancer-specific symptom management intervention is intended as a self-management adjunct to improve cancer- and treatment-related symptoms through non-pharmacologic approaches.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female * Stage 0-III invasive carcinoma of the breast * Surgical resection and axillary assessment, radiation therapy, and/or chemotherapy, as indicated, completed at least 3 months prior to enrollment. * Concomitant trastuzumab and anti-endocrine therapies are permitted. If taking anti-endocrine therapy must have been taking for at least 3 months prior to enrollment. * Must report at least one of the following: 1. Fatigue in the week prior to enrollment at least 4 on a 10 point scale (with 0 = not tired at all and 10 = extremely tired) 2. Insomnia in the week prior to enrollment 3. Pain in the week prior to enrollment at least 4 on a 10 point scale (with 0 = no pain and 10 = extremely severe pain) * Has access to and is able to operate a computer with internet access. * Able to read and understand English. * Willing and able to sign an informed consent document.

Exclusion criteria

\- Diagnosis of sleep apnea or restless leg syndrome that is currently interfering with sleep

Design outcomes

Primary

MeasureTime frameDescription
Improvement in patient-reported symptom with use of PROSPECT for 8 weeks8 weeksTo obtain preliminary data about the efficacy of the intervention in this patient population. The investigators will assess change in the participant's primary reported symptom (pain, insomnia, or fatigue) with 8 weeks of the intervention.

Secondary

MeasureTime frameDescription
Acceptability of the PROSPECT intervention based on patient self-report8 weeksTo obtain preliminary data about the acceptability and usability of the intervention in this patient population.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026